Watch Ticker

Celldex Therapeutics, Inc

Go to Celldex Therapeutics, Inc Website

$22.13

0.00 (0.00%)

Live

Previous Close

$22.13

Day Range

$0 - $0

Previous Day Range

$21.46 - $22.6

Market Cap

$1.4 billion USD

Day Vol.

Previous Day Vol.

935771

Currency

USD

Primary Exchange

Nasdaq

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products ta...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025

Celldex's barzolvolimab demonstrated rapid, robust, and durable improvements in angioedema symptoms over 52 weeks in a Phase 2 study for chronic spontaneous urticaria, with up to 77% of patients being angioedema-free at Week 52.

Related tickers: CLDX.

Read Full Article

N/A - Celldex Therapeutics Presents Positive Preclinical Data from Inflammatory Bispecific Antibody Program CDX-622 at AAAAI 2025

Celldex Therapeutics presented positive preclinical data for its bispecific antibody CDX-622, which targets TSLP and SCF to reduce inflammation and fibrosis. The data showed CDX-622 inhibits TSLP and SCF-dependent activities, and a Phase 1 study in healthy volunteers is ongoing.

Related tickers: CLDX.

Read Full Article

Trending Tickers

Please sign in to view